CXCL10 and hepatocellular carcinoma: Decitabine (DAC), an inhibitor of DNA methylation transferase, is able to induce CXCL10 expression in tumor cells and suppress anti-tumor T-cell responses and hepatoma proliferation when administered to HCC mice (166).